Your address will show here +12 34 56 78


Revolutionizing
Pharma with
AEVOLVE
AEVOLVE is a protocol that supports medical innovations from R&D stages to full-scale commercialization, by connecting patients, investors, and scientific innovators.

 

    

 

01
BIG PHARMA IS SICK 
AND WE ARE THE CURE
AEVOLVE is a powerful channel that brings fintech and revolutionary medical science together to accelerate the financing of medical innovations. It is a practical vehicle for bringing health-related innovations to their next stages of development, so patients can access and benefit from them faster.

At this very moment, scientists, doctors, and biotech innovators around the world are hard at work developing new technologies that will one day change the lives of patients, defeat the world’s worst diseases, and redefine healthcare as we know it.

However, the journey from scientific breakthrough to patient availability is a long, expensive, and resource intensive series of trials, obstacles, compliance, and global regulations. Without proper funding and support, many of these promising breakthroughs find themselves unable to reach commercialization and never help those who need it most.

Today, there is an imbalance of capital sources in healthcare that put profits before patients. Where proven treatments, that reduce costs, cure diseases, routinely sit on shelves or never receive funding, because they simply aren’t profitable enough.

At AEVOLVE, we believe that the time has come to reimagine healthcare by bridging the gaps between patients, innovators, and investors together. Our mission is to empower patients to take control of their healthcare, to find, fund, and deliver the most promising technologies from around the world to improve lives, eradicate diseases, and reduce costs.

AEVOLVE BEP-20 TOKEN ADDRESS
0xea6c643b02ead1e42813771826e64a70a973f3e9

 

ROADMAP
AEVOLVE $AVEX
What we'll be up to
  • Text Hover
Q1 2021
Public Stealth Launch
• Small exchange listings
• Secured AVEX ISIN Swiss Launch
• Expanded core AEVOLVE team
  • Text Hover
Q2 2021
Protocol Development
• Developed BEP-20 version of AVEX Token
• Developed 1:1 AVEX ERC-20/BEP-20 Swap tool
• Developed BEP-20 version of AVEX Token
• Began brand-awareness campaign
• Submitted Coinbase application
• Submitted Binance application
Q2 2021
Protocol Development
• Developed BEP-20 version of AVEX Token
• Developed 1:1 AVEX ERC-20/BEP-20 Swap tool
• Developed BEP-20 version of AVEX Token
• Began brand-awareness campaign
• Submitted Coinbase application
• Submitted Binance application
  • Text Hover
  • Text Hover
Q3 2021
Marketing Push
• Major social media influencer campaigns
• Direct marketing blasts on social media
• CoinDesk hosted webinar
• UniSwap Launch
• PancakeSwap Launch
• Binance DEX Listing
  • Text Hover
Q4 2021
Listings and BIOSPHEREs
• Coinbase Listing
• Binance Listing
• Release of V1.1 of Biosphere ecosystem
Q4 2021
Listings and BIOSPHEREs
• Coinbase Listing
• Binance Listing
• Release of V1.1 of Biosphere ecosystem
  • Text Hover
THE NEW PATH TO PATIENT-DRIVEN TREATMENTS AND CURES
About Aevolve

Aevolve is a protocol that supports medical innovations from R&D stages to full-scale commercialization, by connecting patients, investors, and scientific innovators.

INVESTOR ACCESS TO A BILLION-DOLLAR ECOSYSTEM
AVEX.AI

This new asset class provides exposure to opportunities in blockchain, free of the risks associated with previous token offerings. Coming soon to the the SIX Swiss Stock Exchange.

FOR PATIENTS AND INNOVATORS
BIOSPHERES

This innovation marketplace connects patients and the global community directly with scientific innovators and experts from all over the world to address various stages of the innovation life cycle.

BLOCKCHAIN TOOLS
AVEX Token & The Aevolve Protocol

Cutting-edge medical science meets blockchain-driven technology to create new opportunities to drive innovation.